Judges Scientific plc (the "Company")
6 November 2015
Director/PDMR Shareholding
Judges Scientific has been advised that purchases of Ordinary Shares of 5p each in the Company ("Ordinary Shares") were made on 5 November 2015 by the Trustees of the Share Incentive Plan on behalf of one Director of the Company, as follows:
A total of ten Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,662 Ordinary Shares representing 15.03 per cent of the issued Ordinary share capital. In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.
The purchases by the Trustees were made at a price of 1547.0p per Ordinary Share. Purchases of a further 864 Ordinary Shares were made on the same date and at the same price on behalf of 77 other members of staff under the Plan.
For further information please contact:
Judges Scientific plc
David Cicurel, CEO
Tel: 0203 829 6970
Shore Capital (Nominated Adviser & Broker)
Pascal Keane
Edward Mansfield
Tel: 020 7408 4090
Cardew Group (Financial Public Relations)
Melvyn Marckus
Tel: 020 7930 0777 or 07775 896 491
Website:
Judges Scientific: www.judges.uk.com